Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Learn more › Ready to transform your body before summer? It’s possible with the ShedRx 4-Week Semaglutide Weight Loss Program. It offers personalized care, telehealth consultations ...

Lewis is the owner of Lewis Family Care in Ashland. According to his plea, he bought semaglutide from businesses in California and Georgia that were not approved to distribute the drug for use in ...

But how long can you take semaglutide without your weight loss stalling? We asked experts to weigh in on using the medication long-term. How long can you take semaglutide for optimal weight loss?

Investigators say the misbranded semaglutide, used in weigh loss drugs such as Wegovy, was purchased from suppliers in California and Georgia to administer to patients at a weight loss clinic.

Researchers examined 1733 reports of ocular adverse drug events, comprising 1541 and 192 cases related to injectable forms and oral tablets ... both formulations of semaglutide; adverse drug ...

Resolution of steatohepatitis without worsening of fibrosis occurred in 62.9% of the 534 patients in the semaglutide group and in 34.3% of the 266 patients in the placebo group (estimated ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

“The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of ...